Specification sheet
Tesamorelin / Ipamorelin
- Molecular weight
- 5135.9 / 711.9
- Components
- Tesamorelin + Ipamorelin
- CAS number
- 218949-48-5 / 170851-70-4
- Type
- Peptide blend
- Form
- Lyophilized powder blend
- Sizes
- 14mg
Research access
Lumen supplies research compounds to qualified researchers and laboratories for in-vitro use. Confirm once to enter.
By entering you affirm the statement above is true. Products are not for human or veterinary use, not for diagnostic procedures, and have not been evaluated by the FDA.
99.71%HPLC purity
Research Blends
Two-way GH-axis blend documented per component.
$115.0014mg vial
Buy 1, get 1 free: add a 2nd vial and it is free.
Researchers also added
Mix and match: Buy 1, get 1 free pairs any two vials in your cart. Research use only.
The compound
A blend pairing Tesamorelin, a GHRH(1-44) analog, with Ipamorelin, a selective GHS-R agonist. The two act at different receptors on the growth-hormone axis, which is why they are commonly studied together. Documented per component. Research use only.
Specification sheet
Where it is studied
The Tesamorelin component engages the GHRH receptor on somatotroph models.
The Ipamorelin component is studied for selectivity, with minimal cortisol or prolactin cross-activity.
Dual-receptor pairing is investigated for additive GH-axis readouts. Illustrative only.
In the lab
In laboratory research tesamorelin, a GHRH(1-44) analog, resisted DPP-IV breakdown and raised GH and IGF-1, while ipamorelin released GH through the GHRP (ghrelin) receptor without an ACTH or cortisol rise. The two have been studied separately; no paper has tested them together.

Compound
Tesamorelin / IpamorelinBlend of tesamorelin and ipamorelinGH axis activation
Endpoint studied
Raised GH and IGF-1Resisted DPP-IV, degraded more slowly in plasma than hGRF(1-44), and repeat runs raised GH and IGF-1.Ferdinandi 2007 · PMID 17214611 (opens PubMed in a new tab)Selective GH release
Endpoint studied
GH releaseReleased GH from pituitary cells as potently as GHRP-6; ACTH and cortisol did not rise in laboratory models.Raun 1998 · PMID 9849822 (opens PubMed in a new tab)Research history
5 milestones, each linked to its PubMed record.
1998
Ipamorelin
European Journal of Endocrinology
A pentapeptide from a GHRP-1 chemistry program releases GH like GHRP-6 but leaves ACTH and cortisol unchanged.
PubMed · PMID 9849822 (opens in a new tab)1999
Ipamorelin
Growth Hormone & IGF Research
Raised the longitudinal bone growth rate in a growth model, with total IGF-I unchanged.
PubMed · PMID 10373343 (opens in a new tab)2000
Ipamorelin
The Journal of Endocrinology
Raised bone mineral content in a long-term model through larger bone dimensions, not denser bone.
PubMed · PMID 10828840 (opens in a new tab)2007
Tesamorelin
Basic & Clinical Pharmacology & Toxicology
The hexenoyl group resists DPP-IV and slows plasma breakdown; repeat runs raise GH and IGF-1 in laboratory models.
PubMed · PMID 17214611 (opens in a new tab)2009
Tesamorelin
Expert Opinion on Investigational Drugs
A review traces how tesamorelin was developed as a synthetic analog of human growth hormone releasing factor.
PubMed · PMID 19243281 (opens in a new tab)Laboratory research only, cited for research context. Not a claim about use in people.
Catalog peptides are specified at 99%+ identity purity. Each lot is verified by an independent laboratory using HPLC and mass spectrometry, and the results are published in that lot's Certificate of Analysis.
A COA is the lab document issued for a specific production lot. It records the compound's identity confirmation, measured purity and the lot number, so the vial on the bench can be traced back to its test results.
Orders placed before the daily cutoff ship the same or next business day from a US facility. Lyophilized peptides are stable in transit and do not require cold shipping.
L-H2O is a sterile, USP-grade laboratory solvent containing 0.9% benzyl alcohol. It is a bench accessory, not a peptide, and carries no HPLC purity claim or COA.
Research use only. Sold strictly for in-vitro laboratory research by qualified professionals. Not for human or veterinary use, not for diagnostic or therapeutic procedures, and not evaluated by the FDA.